If GNBT Qs being fielded: Excellagen - How do you
Post# of 36537
If issues persist with funding, how will Excellagen be rolled out without funding? From previous statements you have made, this product would appear to have margins which would make it a very good candidate for self-funding through the sales ramp up. Patents are aging, yet we are still not capitalizing on this product’s potential, both for its own sake and also it’s potential to fund other initiatives.